Assembly Biosciences (ASMB) PT Lowered to $15 at Truist Securities
Tweet
Share
E-mailGet Alerts ASMB Hot Sheet
Price: $32.02 -2.82%
Rating Summary:
7 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
7 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Truist Securities analyst Nicole Germino lowered the price target on Assembly Biosciences (NASDAQ: ASMB) to $15.00 (from $45.00) while maintaining a Buy rating.
You May Also Be Interested In
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
- RCM Technologies (RCMT) PT Raised to $45 at Benchmark on Q2 Beat
- Mabuchi Motor Co Ltd. (6592:JP) (MBUMY) PT Raised to JPY1,730 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
